Early within therapy naming probes as a clinically-feasible predictor of anomia treatment response.

Aphasia anomia behavioural predictors language rehabilitation

Journal

Neuropsychological rehabilitation
ISSN: 1464-0694
Titre abrégé: Neuropsychol Rehabil
Pays: England
ID NLM: 9112672

Informations de publication

Date de publication:
22 Feb 2023
Historique:
pubmed: 23 2 2023
medline: 23 2 2023
entrez: 22 2 2023
Statut: aheadofprint

Résumé

This study investigated the relationship between early within-therapy probe naming performance and anomia therapy outcomes in individuals with aphasia. Thirty-four adults with chronic, post-stroke aphasia participated in the Aphasia Language Impairment and Functioning Therapy (Aphasia LIFT) programme, comprised of 48 h of comprehensive aphasia therapy. Sets of 30 treated and 30 untreated items identified at baseline were probed during impairment therapy which targeted word retrieval using a combined semantic feature analysis and phonological component analysis approach. Multiple regression models were computed to determine the relationship between baseline language and demographic variables, early within-therapy probe naming performance (measured after 3 h of impairment therapy) and anomia treatment outcomes. Early within-therapy probe naming performance emerged as the strongest predictor of anomia therapy gains at post-therapy and at 1-month follow-up. These findings have important clinical implications, as they suggest that an individual's performance after a brief period of anomia therapy may predict response to intervention. As such, early within-therapy probe naming may provide a quick and accessible tool for clinicians to identify potential response to anomia treatment.

Identifiants

pubmed: 36811618
doi: 10.1080/09602011.2023.2177312
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-24

Auteurs

Jade Dignam (J)

Queensland Aphasia Research Centre, The University of Queensland, Brisbane, Australia.
School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.
Surgical Treatment and Rehabilitation Service (STARS) Education and Research Alliance, The University of Queensland and Metro North Hospital Service, Brisbane, Australia.

Amy D Rodriguez (AD)

Center for Visual and Neurocognitive Rehabilitation, Atlanta VA Health Care System, Decatur GA, USA.
Department of Neurology, Emory University School of Medicine, Atlanta GA, USA.

Kate O'Brien (K)

Queensland Aphasia Research Centre, The University of Queensland, Brisbane, Australia.
Surgical Treatment and Rehabilitation Service (STARS) Education and Research Alliance, The University of Queensland and Metro North Hospital Service, Brisbane, Australia.

Penni Burfein (P)

Surgical Treatment and Rehabilitation Service (STARS) Education and Research Alliance, The University of Queensland and Metro North Hospital Service, Brisbane, Australia.
Department of Speech Pathology and Audiology, Surgical Treatment and Rehabilitation Service, Metro North Hospital and Health Service, Brisbane, Australia.
Department of Speech Pathology and Audiology, The Royal Brisbane and Women's Hospital, Metro North Hospital and Health Service, Brisbane, Australia.

David A Copland (DA)

Queensland Aphasia Research Centre, The University of Queensland, Brisbane, Australia.
School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.
Surgical Treatment and Rehabilitation Service (STARS) Education and Research Alliance, The University of Queensland and Metro North Hospital Service, Brisbane, Australia.

Classifications MeSH